Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Anuh Pharma Limited ( (IN:ANUHPHR) ) has shared an announcement.
Anuh Pharma Limited has notified the stock exchanges that its unaudited financial results for the quarter ended 31 December 2025 have been published in leading English and Marathi newspapers. The company has also provided a QR code and webpage details in the advertisements, and simultaneously uploaded the full results on its corporate website, reinforcing regulatory compliance and transparency for investors.
The disclosure confirms that the quarterly and nine‑month financial statements were reviewed by the audit committee and approved by the board in early February 2026. By disseminating results across exchanges, print media, and digital platforms, Anuh Pharma signals adherence to SEBI’s listing obligations and facilitates easier access to its financial performance data for shareholders and market participants.
More about Anuh Pharma Limited
Anuh Pharma Limited is an Indian pharmaceutical company engaged in manufacturing and marketing active pharmaceutical ingredients and related products for domestic and export markets. Listed on both BSE and NSE, it targets institutional buyers and formulators, operating under India’s regulated disclosure framework for publicly traded companies.
Average Trading Volume: 5,856
Technical Sentiment Signal: Buy
Current Market Cap: 7.96B INR
For detailed information about ANUHPHR stock, go to TipRanks’ Stock Analysis page.